FDA Investigator Joseph W Matthews
Joseph W Matthews has conducted inspections on 77 sites in 1 countries as of 08 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
77
Last Inspection Date:
08 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Joseph W Matthews:
Alice S Tsao,
Alison N Stieg,
Amanda B Athey,
Amanda B Vega,
Amber G Chung,
Anthony W Hite,
Ashley M Whitehurst,
Austin B Appler,
Azeezat M Lawal,
Barbara A Burke,
Barbara A Gullick,
Barbara J Holladay,
Bijoy Panicker,
Brandon L Mariner,
Brooke K Higgins,
Carrie L Doupnik,
Chaltu Nwakijra,
Charles D Boison,
Charles E Idjagboro,
Charles M Kerns, BLT DO,
Chiang Syin, PhD,
Christina K Theodorou,
Christine W Twohy,
Clarice J Ahn,
Danielle R Rainey,
David A Oluwo,
David L Chon,
Denise R Beuttenmuller,
Dhaval H Patel,
Diane T Bargo,
Douglas A Campbell,
Dr. Dominick Roselle,
Dr. Roslyn F Powers,
Dr. Yubing Tang,
Dung N Tran,
Edette J Newby,
Edmund F Mrak, Jr,
Edward P Potter,
Elizabeth A Laudig,
Elvis D Morton,
Emest F Bizjak,
Emmanuel A Dimaano, Jr,
Erika M Wilkerson,
Erin L Mcfiren,
Gail L Katz,
Gale L Glinecki,
George Pyramides,
Heath R Harley,
Hector Jcolon Torres,
Holly S Simms,
Hugh M Mcclure, II,
James M Mason,
James M Simpson,
James T Mccoy,
James W Leonette,
Janete F Guardia,
Jeanne D Shaffer,
Jessica D Nanini,
John Dan,
John M Gusto,
Johnny D Nwankwo,
Johnson,
Jonah S Ufferfilge,
Jonathan W Chapman,
Julie A Silberberg,
Junho Pak,
Justin A Hefferman,
Justin H Price,
Karen M Cooper,
Kathleen M Jordan,
Keith M Reilly,
Kenneth L Smalls,
Kenneth M Gordon,
Kenneth Nieves,
Ko U Min,
Krista N Flores,
Kristina L Conroy,
La Tasham Gunter,
Lakisha M Williams,
Latoya S Oliver Powell,
Laurianne M Montonye,
Laurissa S Flowers,
Lawrence Harmon, Jr,
LCDR Anastasia M Piliafas Brown,
Linda J Eason,
Linda S Mattingly,
Lori S Lawless,
LT Luis O Rodriguez,
LT Melanie M Mayor, USPHS,
Lynette P Salisbury,
Marcellinus D Dordunoo,
Marcus A Ray,
Margaret M Doherty,
Margaret Torres Vazquez,
Marion W Nadeau,
Matthew M Henciak,
Melissa D Kalik,
Melissa J Garcia,
Merideth K Rose,
Michael L Zimmerman,
Michael Shanks, MS,
Michele M Falchek,
Mildred L Mccray,
Monique Rac Lester,
Myra L Gemmill,
Myra L Reed,
Nancy L Meade,
Natasha A Dezinna,
Nebil A Oumer,
Nerizza B Guerin,
Nicholas A Violand,
Nina D Patel,
Nisha C Patel,
Osama M Hamoud,
Pamela N Agaba,
Patricia A Morrow,
Patrick C Klotzbuecher,
Paula J Bretz,
Philip W Beck,
Qin Xu,
Rachael O Oyewole,
Rachel C Harrington,
Regina Gibson Melton,
Renisha M Shaw,
Richard J Bashay,
Robert J Martin,
Ronald T Nowalk,
Sharon K Thoma, PharmD,
Shirshendu K Deb, PhD,
Shusheen A Alexander,
Simone E Pitts,
Slatten,
Stacey A Priest,
Stephanie L Shapley,
Stephanie Mangigian, MS/OSH, RN,
Steven P Donald,
Suzanne M Healy,
Sylvia R Dooling,
Tamara N Champion,
Tamika E Allen, RN,
Tania E Vizcaino,
Tekalign Wondimu,
Theresa M Smedley,
Tonia F Bernard,
Toyin B Oladimeji,
Valerie G Vallely,
Victoria V Bot,
Viviana Matta,
Vivin George,
Walter L Fava,
Wanda Y Fields,
Wanda Y Honeyblue,
Wayne L Jefferson,
William H Linkroum,
Yvins Dezan,
Zhongren Wu
Joseph W Matthews's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2002 | FDA 483 | Pharmaceutics International, Inc. - Form 483, 2002-11-14 |
November, 2002 | FDA 483 Response | Pharmaceutics International, Inc. - Form 483R, 2002-11-14 |
November, 2002 | EIR | Pharmaceutics International, Inc. - EIR, 2002-11-14 |
May, 2003 | EIR | Baltimore Washington Medical Center - EIR, 2003-05-29 |
March, 2003 | FDA 483 Response | Frank J. Criado, MD - Form 483R, 2003-03-18 |
January, 2007 | EIR | Ani Lytics, Inc. - EIR, 2007-01-17 |
March, 2003 | FDA 483 | Frank J. Criado, MD - Form 483, 2003-03-14 |
March, 2003 | EIR | Frank J. Criado, MD - EIR, 2003-03-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more